Chesnara (LON:CSN – Get Free Report) had its price objective upped by equities research analysts at Berenberg Bank from GBX 333 to GBX 339 in a research note issued to investors on Wednesday,London Stock Exchange reports. The firm currently has a “buy” rating on the stock. Berenberg Bank’s price objective suggests a potential upside of 12.83% from the stock’s previous close.
Chesnara Stock Performance
Shares of CSN stock opened at GBX 300.45 on Wednesday. The stock’s 50-day simple moving average is GBX 307.80 and its 200-day simple moving average is GBX 292.10. The firm has a market capitalization of £692.78 million, a PE ratio of -59.50 and a beta of 0.49. Chesnara has a fifty-two week low of GBX 245.50 and a fifty-two week high of GBX 335.
Chesnara (LON:CSN – Get Free Report) last announced its quarterly earnings data on Tuesday, March 24th. The company reported GBX (5.05) earnings per share for the quarter. Chesnara had a negative net margin of 1.01% and a negative return on equity of 2.43%. Sell-side analysts forecast that Chesnara will post 25.3183154 earnings per share for the current year.
Insider Transactions at Chesnara
About Chesnara
Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three-pillar strategy, Chesnara’s primary responsibility is the efficient administration of its customers’ life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.
See Also
Receive News & Ratings for Chesnara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara and related companies with MarketBeat.com's FREE daily email newsletter.
